Trials / Completed
CompletedNCT03232528
The Promotion Plan of Moxibustion on Ulcerate Colitis
A Study on the Promotion Plan of the Moxibustion Treatment of Ulcerate Colitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Shanghai Institute of Acupuncture, Moxibustion and Meridian · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the efficacy of Moxibustion in the treatment of Ulcerative Colitis, thus the scientific foundation for rational use of Moxibustion in clinical usage, in order to find admission of the Acupuncture and Moxibustion and even medicine field, accomplish popularization and application.
Detailed description
A total of 128 patients with UC were randomly divided into the following 2 groups: a) Herb-partition moxibustion (Treatment Group) and b) Sham herb-partition moxibustion (Control Group). All patients in the trial will be treated with moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. After treating the treatment had ended and the 52nd week of follow-up to observe the clinical therapy effect of Moxibustion in UC patients. Tissue morphology and molecular biology tests will be conducted to observe the regulation in the intestinal mucosa of UC patients. All these steps will be done in order to provide clinical usage for the effects of herb-partition moxibustion in the treatment of UC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Herb-partitioned moxibustion | Patients receive herb-partition moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. |
| OTHER | Sham herb-partitioned moxibustion | Patients receive sham herb-partition moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-12-30
- Completion
- 2019-12-30
- First posted
- 2017-07-28
- Last updated
- 2021-03-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03232528. Inclusion in this directory is not an endorsement.